Balchem (BCPC) Stock Price
Balchem Price
Over the last 19 years Balchem grew revenue by 13.0% annually, reaching 1.04 B USD. Earnings per share have grown at 13.2% per year over the last 19 years. For Balchem, the net margin of 14.9% is up versus 12.0% a few years ago. At today's price the dividend yield works out to roughly 0.55%. The payout ratio is around 20% of earnings. The dividend has grown at 15.7% per year over the past 19 years. The consensus 12-month price target for Balchem is 215.00 USD, about 23.7% above where the stock trades today. Of 10 analysts, 8 rate the stock a buy — an overall Buy consensus.
Balchem stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balchem business model & stock analysis
Frequently asked questions about Balchem
Balchem Corp is a leading company with a unique business model. The company specializes in the development, manufacturing, and marketing of specialty performance ingredients and products, catering to various industries. Balchem Corp focuses on providing innovative solutions that enhance the health and well-being of people, animals, and plants. With a diverse portfolio, the company offers nutritional, flavor, and fragrance ingredients, as well as animal health products and specialty film solutions. Balchem Corp consistently aims to deliver high-quality products and services that meet the evolving needs of its customers, reinforcing its position as a trusted industry leader.
Balchem Corp is primarily active in the industries of nutrition and health, animal nutrition, specialty products, and industrial products.
The main competitors of Balchem Corp in the market include companies such as Archer Daniels Midland Company, Innophos Holdings Inc., and Corbion N.V.
Balchem Corp is a leading company in the specialty chemicals industry. Founded in 1967, Balchem Corp has established a strong reputation for delivering innovative solutions across various sectors including human and animal nutrition, food and beverage, and pharmaceuticals. The company's rich history spans over five decades, marked by continuous growth and strategic acquisitions. Balchem Corp remains committed to providing high-quality products and services, leveraging its expertise in encapsulation, chelation, and controlled release technologies. With a customer-centric approach and a focus on sustainable solutions, Balchem Corp continues to drive forward in its mission to enhance health and well-being through its diverse portfolio of products and cutting-edge research.
Balchem Corp has achieved several significant milestones in its history. One of the key milestones is its acquisition of certain assets of Animal Nutrition & Health (ANH) business from a leading global food company, AkzoNobel, in 2012. This acquisition allowed Balchem to expand its portfolio and become a leading provider of encapsulated nutraceuticals for both human and animal health markets. Additionally, the company has consistently demonstrated strong financial performance over the years, with increasing revenues and earnings. Furthermore, Balchem has established itself as a trusted name in the industry, known for its high-quality products and innovative solutions.
Balchem Corp is primarily present in the United States.
Balchem Corp represents a commitment to innovation, sustainability, and to making a positive impact in the industries it serves. The company focuses on delivering high-quality, science-based solutions that provide unique value to its customers. Balchem Corp places a strong emphasis on corporate responsibility, striving to operate in a socially and environmentally responsible manner. With a dedicated team and a customer-centric approach, the company aims to consistently provide exceptional products and services that meet the evolving needs of its clients.
Analysts currently set an average price target of 215.00 USD for the Balchem stock (median: 215.00 USD), implying +23.7 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Balchem stock: 8 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Balchem to generate revenue of 1.13 B USD and earnings per share of 5.53 USD.
Converted at the current exchange rate, the Balchem share trades at 155.32 EUR (173.88 USD).
The Balchem share (BCPC) is listed on 5 stock exchanges, including: NASDAQ (BCPC), SIX (Zürich) (BL9B.SW), Frankfurt (BL9B.F), München (BL9B.MU), Düsseldorf (BL9B.DU).
Balchem Corp is a leading company in the fields of animal nutrition, human nutrition, and industrial chemicals. The innovative company offers a wide range of products and solutions tailored to the needs of its customers. Balchem's animal nutrition division provides solutions for animal feed enhancement, health, and well-being of livestock, pets, and aquaculture. Balchem's products help animal owners improve the health of their animals and increase growth and productivity. Balchem uses innovative technologies to offer its customers powerful and effective feed enhancement solutions that provide significant benefits for animal health and performance. Balchem's human nutrition division offers solutions tailored to the health and needs of the modern consumer. Balchem's products include functional ingredients, vitamins, minerals, and amino acids used in food, beverages, supplements, and pharmaceutical products. Balchem aims to improve human health and well-being by offering innovative products that help consumers maximize their health and happiness. Balchem's industrial chemicals division offers a variety of solutions for applications in agriculture, industry, and other industries. Balchem produces and distributes chemicals that can be used for many different purposes, including pesticides, defoliants, flame retardants, and many more. Balchem leverages its experience and expertise in the chemical industry to offer innovative solutions to its customers, helping them achieve their business goals. An example of a Balchem product is Choline Chloride, which is known as an essential nutrient for animals. It supports the growth and maintenance of cells and tissues, especially the nervous system. It is necessary for the synthesis of lecithin, which is an important component of any cell membrane. Overall, Balchem's business model is based on providing innovative, customer-oriented solutions tailored to the needs of its customers. The company has a strong focus on research and development of new products and technologies, which allows it to continuously enter new markets and remain competitive. By continuously evolving high-quality products and services, Balchem creates value for its customers and supports them in achieving their goals.
The expected revenue of Balchem is 1.13 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Balchem is 178.67 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Balchem is currently 31.45. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Balchem stock.
The price-to-sales ratio (P/S) of Balchem is currently 4.96. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Balchem stock.
The Eulerpool Quality Score for Balchem is 6/10.
The ISIN of Balchem is US0576652004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Balchem is 905650. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Balchem is BCPC. The ticker symbol is used to trade Balchem shares on the stock exchange.
Balchem stock
Balchem Peer Group
Balchem Ticker
Balchem FIGI
All fundamentals and in-depth analysis of Balchem
Our stock analysis for Balchem stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Balchem. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.